Skip to Main Content

Paper Details

Evaluating the Potential Benefits of Using Sustained Response as a Prognostic Factor in Intermediate Hepatocellular Carcinoma Following Treatment With Conventional Chemoembolization.
JAMA Netw Open
0
2018

Datasets

Release 1.2